Osteoinductive & osteoconductive biomaterials now play a crucial role in the treatment of traumatic, developmental, and pathological bone defects. Their purpose is to substitute or repair damaged bone. These biomaterials can be permanent or temporary and come in various forms, both natural (e.g., allografts and xenografts) and synthetic (e.g., alloplasts, metals, ceramics, polymers, and composites).…

Determining cytotoxicity is a critical step in assessing the biocompatibility of medical devices, biomaterials, and drug screening. There are a wide variety of methods available to researchers; however, too often cell-based assay results indicating poor cell health without greater context slow down or halt progress on the development of a medical device. Technology is constantly…

Ensuring that new products get to market is a top priority for R&D teams, as delays can significantly impact ROI. But the actual cost of pre-clinical research delays comes from studies that must be repeated due to incorrect testing. iFyber President, Greg Mouchka, offers insights on how to avoid these expensive mistakes. Challenges in Pre-Clinical…

All medical device manufacturers strive to ensure devices and biomedical technologies are safe, efficacious, and fit for intended use. The biggest roadblock to accomplishing this is medical device testing to determine the most appropriate regimen for the device and its use. Although speed to market is key, medical device manufacturers must devise and implement an…